In melanoma cell lines, transcriptional factor HIF-1a interacts with FLNACT and then is translocated into the nucleus to bind to the VEGF promoter to increase xenograft tumor progression and angiogenesis [12] (Table 1). Here, HIF1A is linked to neoplasm.